Imagine Eyes

Retinal diseases cause visual disability and blindness in over 400 million people worldwide. Imagine Eyes mission is to enhance the diagnosis and management of these sight-threatening diseases, and improve visual health throughout the world. To do so, the company offers medical imaging devices that detect earlier signs of pathology at the back of the eye, deliver quicker readouts of treatment effectiveness, and enable more personalized retinal therapies. Imagine Eyes products combine advanced biophotonics imaging with adaptive optics, a breakthrough technology derived from the area of astrophysics. As a result, they deliver images with microscopic resolution, and doctors can examine patients...

Retina,imaging,diagnostics,medical devices,biomarkers,ophthalmology,cardiology,internal medicine,neurology,age-related macular degeneration,inherited retinal diseases,diabetic retinopathy,diabetes,cardiovascular,neurovascular,prevention,microcirculation,photoreceptors,geographic atrophy,clinical trials,and endpoints

Imagine eyes operates in the Medical device industry.

Imagine eyes's revenue is 1m - 10m

Imagine eyes has 11 - 50 employees.